CSL Limited

ASX (AUD): CSL Limited (CSL)

Last Price

311.70

Today's Change

+0.58 (0.18%)

Day's Change

307.33 - 311.70

Trading Volume

1,374,357

Overview

Market Cap

150 Billion

Shares Outstanding

483 Million

Avg Volume

721,416

Avg Price (50 Days)

289.80

Avg Price (200 Days)

278.37

PE Ratio

41.23

EPS

7.56

Earnings Announcement

13-Aug-2024

Previous Close

311.12

Open

308.37

Day's Range

307.33 - 311.7

Year Range

228.65 - 311.7

Trading Volume

1,374,357

Price Change Highlight

1 Day Change

0.19%

5 Day Change

0.90%

1 Month Change

7.21%

3 Month Change

15.66%

6 Month Change

7.85%

Ytd Change

8.12%

1 Year Change

17.49%

3 Year Change

8.80%

5 Year Change

40.53%

10 Year Change

361.16%

Max Change

37590.45%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment